Invitrogen™ M-MLV Reverse Transcriptase (200 U/µL)

M-MLV Reverse Transcriptase is a recombinant DNA polymerase that synthesizes a complementary DNA strand from single-stranded RNA, DNA, or an RNA:DNA

biotechrabbit, MMuLV Reverse Transcriptase, 200 U/µl

Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites - eBioMedicine

A low-cost and open-source protocol to produce key enzymes for molecular detection assays - ScienceDirect

Invitrogen SuperScript II Reverse Transcriptase is a genetically engineered MMLV reverse transcriptase (RT) with reduced RNase H activity and

Invitrogen™ SuperScript™ II Reverse Transcriptase

Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological

Maxima Reverse Transcriptase (200 U/µL)

is an engineered mutant of MMLV providing increased specificity and exceptionally high cDNA yields even with complex RNA templates such as viral

HighTherm™ Reverse Transcriptase

LaboShop, Products

Frontiers In vitro effects of European and Latin-American medicinal plants in CYP3A4 gene expression, glutathione levels, and P-glycoprotein activity

Ultrapure SMART MMLV Reverse Transcriptase for RT-PCR